Clinical Trials Browser

Phase 3 × Gastric Adenocarcinoma × Docetaxel × Clear all

NCT01283217 2013-06-04

Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric Cancer

Phase 3 Unknown

Gastrointestinal

Gastric Adenocarcinoma